British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015
- PMID: 27568911
- DOI: 10.1111/hiv.12426
British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015
Similar articles
-
British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012 (Updated November 2013. All changed text is cast in yellow highlight.).HIV Med. 2014 Jan;15 Suppl 1:1-85. doi: 10.1111/hiv.12119. HIV Med. 2014. PMID: 24330011 No abstract available.
-
British HIV Association Guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008.HIV Med. 2008 Oct;9(8):563-608. doi: 10.1111/j.1468-1293.2008.00636.x. HIV Med. 2008. PMID: 18826546 No abstract available.
-
[Antiretroviral therapy in 2004].MMW Fortschr Med. 2004 Apr 26;146 Spec No 1:46-8, 50-1. MMW Fortschr Med. 2004. PMID: 15373049 German.
-
Managing HIV/AIDS patients.N J Med. 1998 May;95(5):55-60. N J Med. 1998. PMID: 16013158 Review. No abstract available.
-
Impact of HIV infection and antiretroviral therapy in the older patient.Expert Rev Anti Infect Ther. 2004 Dec;2(6):821-4. doi: 10.1586/14789072.2.6.821. Expert Rev Anti Infect Ther. 2004. PMID: 15566324 Review. No abstract available.
Cited by
-
Profile of cabotegravir and its potential in the treatment and prevention of HIV-1 infection: evidence to date.HIV AIDS (Auckl). 2016 Oct 14;8:157-164. doi: 10.2147/HIV.S97920. eCollection 2016. HIV AIDS (Auckl). 2016. PMID: 27799824 Free PMC article. Review.
-
p24 revisited: a landscape review of antigen detection for early HIV diagnosis.AIDS. 2018 Sep 24;32(15):2089-2102. doi: 10.1097/QAD.0000000000001982. AIDS. 2018. PMID: 30102659 Free PMC article. Review.
-
Combined models for pre- and post-treatment longitudinal biomarker data: an application to CD4 counts in HIV-patients.BMC Med Res Methodol. 2016 Sep 15;16:121. doi: 10.1186/s12874-016-0187-2. BMC Med Res Methodol. 2016. PMID: 27633882 Free PMC article.
-
Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial.Lancet Infect Dis. 2018 Jan;18(1):47-57. doi: 10.1016/S1473-3099(17)30630-8. Epub 2017 Nov 3. Lancet Infect Dis. 2018. PMID: 29108797 Free PMC article. Clinical Trial.
-
Determining the Origins of Human Immunodeficiency Virus Type 1 Drug-resistant Minority Variants in People Who Are Recently Infected Using Phylogenetic Reconstruction.Clin Infect Dis. 2019 Sep 13;69(7):1136-1143. doi: 10.1093/cid/ciy1048. Clin Infect Dis. 2019. PMID: 30534981 Free PMC article.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical